These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Procollagen-type III-peptide serum concentrations in chronic persistent and chronic active hepatitis and in cirrhosis of the liver and their diagnostic value. Raedsch R, Stiehl A, Waldherr R, Mall G, Gmelin K, Götz R, Walker S, Czygan P, Kommerell B. Z Gastroenterol; 1982 Dec; 20(12):738-43. PubMed ID: 7164528 [Abstract] [Full Text] [Related]
3. [Comparison of six potential serum markers of hepatic fibrosis in alcoholic disease of the liver]. Grimbert S, Trinchet JC, Hartmann DJ, Munz C, Garnier M, Mal F, Callard P, Beaugrand M. Gastroenterol Clin Biol; 1993 Dec; 17(8-9):570-7. PubMed ID: 8253314 [Abstract] [Full Text] [Related]
4. Urine products of bone breakdown as markers of bone resorption and clinical usefulness of urinary hydroxyproline: an overview. Simsek B, Karacaer O, Karaca I. Chin Med J (Engl); 2004 Feb; 117(2):291-5. PubMed ID: 14975218 [Abstract] [Full Text] [Related]
14. Methods for measuring hydroxyproline and estimating in vivo rates of collagen synthesis and degradation. McAnulty RJ. Methods Mol Med; 2005 Feb; 117():189-207. PubMed ID: 16118453 [Abstract] [Full Text] [Related]
20. [Basic study on the bone growth--metabolism of MPS and collagen]. Nakagawa M, Sugiura Y. Seikei Geka; 1966 Nov; 17(11):845-9. PubMed ID: 4227280 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]